Situation: A 61-year-old woman with lung cancer that has spread to the bones is admitted to the oncology ward for symptom control. Her goal is to stay comfortable. Her bone pain is 8 out of 10. At home she took only paracetamol and ibuprofen and has never used an opioid. Which new order should the nurse clarify with the provider?

Transdermal fentanyl is only for opioid-tolerant clients, defined as taking at least about 60 mg of oral morphine a day or its equivalent for a week or longer; in an opioid-naive client it can cause fatal respiratory depression, and its onset takes 12 to 24 hours. For severe cancer pain, a strong opioid may be started directly, around the clock with breakthrough doses, and a stimulant laxative is started with the opioid.

Core issue The patient has severe cancer-related bone pain (8/10) and has never used an opioid. The order that must be clarified is the transdermal fentanyl patch, because this formulation is reserved for patients who are already opioid-tolerant.

Why fentanyl is unsafe here Transdermal fentanyl delivers drug continuously through the skin, but the onset is slow, taking about 12 to 24 hours to reach meaningful effect. More importantly, in an opioid-naive patient, a fentanyl patch can produce fatal respiratory depression because the dose cannot be quickly removed once absorbed. The consensus guidance and recent clinical reviews consistently state that sublingual and transdermal fentanyl are contraindicated in patients who are opioid-naive ^[4]. Opioid tolerance is strictly defined, generally as taking at least the equivalent of 60 mg of oral morphine daily for one week or longer. This patient has taken only paracetamol and ibuprofen, so she does not meet that threshold.

Why the other orders are appropriate For severe cancer pain, starting a strong opioid immediately is acceptable even in an opioid-naive patient, provided the route and formulation are appropriate. Oral oxycodone given around the clock at 5 mg every 4 hours is a reasonable initial strong-opioid regimen, and a breakthrough dose of 5 mg every 2 hours as needed supports pain control between scheduled doses. Because opioids reduce bowel motility, starting a stimulant laxative such as senna at the same time is standard practice to prevent opioid-induced constipation .

Order	Safety concern	Action
Oxycodone 5 mg PO q4h around the clock	Appropriate starting dose for severe pain in opioid-naive patient	Administer as ordered
Senna 2 tablets PO at bedtime daily	Prevents opioid-induced constipation	Administer as ordered
Fentanyl 25 mcg/h patch q72h	Contraindicated in opioid-naive patient; risk of fatal respiratory depression	Clarify with provider
Oxycodone 5 mg PO q2h PRN breakthrough	Appropriate breakthrough dosing with scheduled opioid	Administer as ordered

Watch out! Do not confuse the route of fentanyl with the drug itself. Short-acting intravenous or transmucosal fentanyl can be used cautiously in opioid-naive patients under close monitoring, but the transdermal patch is specifically contraindicated because of its prolonged, difficult-to-reverse delivery ^[4].

Key point! The decision to start a strong opioid is based on pain severity, not prior opioid exposure. However, the formulation must match the patient’s opioid tolerance. An opioid-naive patient with severe pain can receive oral morphine or oxycodone, but not a transdermal fentanyl patch ^[4].